Our team quickly verifies coverage and matches you with a provider in Chesapeake, Virginia who accepts your insurance
References Campbell, R., Bellolio, F., Motosue, M., et al
Its not yet approved, so the conversation with a doctor right now is about whats in the pipeline, whether current GLP-1 options are working, and whether to watch for survodutide trials to participate in, she said
This can affect your strength, metabolism and overall health if not addressed through diet and exercise
While injectable GLP-1 receptor agonists such as semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) have transformed the treatment landscape for obesity and type 2 diabetes, their reliance on subcutaneous injection remains a significant barrier to broader adoption
Healthcare professionals must consider whether weight loss will meaningfully improve health outcomes and quality of life in older patients, taking into account their overall clinical picture and life expectancy
